Preventing alpelisib-related hyperglycaemia in HR+/HER2-/ PIK3CA-mutated advanced breast cancer using metformin (METALLICA): a multicentre, open-label, single-arm, phase 2 trial

Colaboración

Año: 2024

Llombart-Cussac, A; Perez-Garcia, JM; Borrego, MR; Tolosa, P; Blanch, S; Fernandez-Ortega, A; Urruticoechea, A; Blancas, I; Saura, C; Rojas, B; Bermejo, B; Lorenzo, JP; Gion, M; Cortez-Castedo, P; Llabres, E; Galve, E; Cueva, JF; Lopez, A; Alonso-Romero, JL; Gonzalez-Santiago, S; de Duenas, EM; Ciruelos, E; Martrat, G; Gener, P; Alcala-Lopez, D; Sampayo-Cordero, M; Gomez-Peralta, F; Cortes, J

Título: ECLINICALMEDICINE

• D1